Friday, 30 October 2020


Neil McCullough is Icon's executive VP of quality

28 May 2013 | News | By BioSpectrum Bureau

Dr Neil McCullough – The new executive vice president of quality, compliance and corporate training at Icon

Dr Neil McCullough – The new executive vice president of quality, compliance and corporate training at Icon

Singapore: Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, appointed Dr Neil McCullough as executive vice president of quality, compliance and corporate training.

In this role, Dr McCullough will provide strategic direction for quality management, quality assurance and corporate training across all Icon lines of business, ensuring that the firm continues to deliver high quality solutions to clients that are fully compliant with the evolving global regulations guiding the biopharmaceutical industry.

Dr McCullough brings to Icon over 22 years of experience leading global quality functions for pharmaceutical and clinical research organizations. Prior to Icon, Dr McCullough led the global quality and compliance division of PPD, before which he spent nine years at Pfizer as a member of the Pfizer Global Medical Quality Assurance Leadership team. Prior to Pfizer, Dr McCullough served as a quality consultant to GlaxoSmithKline's division of manufacturing.

Dr McCullough earned his doctorate in chemistry from the University of Kent at Canterbury, UK, and his masters in pharmaceutical medicine from Hibernia College, Dublin, UK, in partnership with Harvard University and the Royal College of Physicians, Ireland.

Commenting on the appointment, Mr Ciaran Murray, CEO, Icon, said that, "I would like to welcome Dr McCullough to Icon's executive leadership team. Delivering quality data and services to the standards required by clients and that are fully compliant with the evolving requirements of regulatory authorities underpins everything we do. Dr McCullough's leadership and industry expertise will allow us to further enhance the quality and compliance solutions we offer to clients in support of their global drug development programmes."


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account